Similarly to mPDAC, N6L reduced the KPC tumour growth (Supplementary Figure S2A) and increased the number of tumour-infiltrated CD8+ T cells in tumours (Supplementary Figure S2B). This evidence concerns the gene CD8A and neoplasm.